Conversely after c-Met silencing, MDA-MB-231 lost their susceptibility to ASCs, which demonstrated unable to sustain tumor growth and aggressiveness when co-injected with MDA-MB-231shMet (Fig.7D). This evidence concerns the gene MET and neoplasm.